Opiant Pharmaceuticals (OPNT) Director Thomas T. Thomas Sells 4,300 Shares

Opiant Pharmaceuticals (NASDAQ:OPNT) Director Thomas T. Thomas sold 4,300 shares of Opiant Pharmaceuticals stock in a transaction dated Tuesday, May 15th. The stock was sold at an average price of $18.35, for a total transaction of $78,905.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Opiant Pharmaceuticals opened at $17.49 on Wednesday, according to Marketbeat.com. Opiant Pharmaceuticals has a 12-month low of $17.77 and a 12-month high of $17.77. The company has a market capitalization of $46.77 million, a PE ratio of 5.95 and a beta of -0.57.

A hedge fund recently raised its stake in Opiant Pharmaceuticals stock. Spark Investment Management LLC grew its holdings in Opiant Pharmaceuticals (NASDAQ:OPNT) by 46.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 20,400 shares of the technology company’s stock after purchasing an additional 6,500 shares during the period. Spark Investment Management LLC owned approximately 0.99% of Opiant Pharmaceuticals worth $468,000 at the end of the most recent quarter. Hedge funds and other institutional investors own 3.71% of the company’s stock.

Separately, ValuEngine raised shares of Opiant Pharmaceuticals from a “sell” rating to a “hold” rating in a research report on Wednesday, April 4th.

About Opiant Pharmaceuticals

Opiant Pharmaceuticals, Inc, a specialty pharmaceutical company, develops pharmacological treatments for substance use, addictive and eating disorders. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes treatments for eating disorders, including bulimia nervosa and binge eating disorders, alcohol use disorders, a long term treatment to prevent relapse for patients with opioid use disorders, cocaine use disorders, and a heroin vaccine.

Receive News & Ratings for Opiant Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Opiant Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

LaSalle Street Capital Management LLC Sells 833 Shares of FedEx Co.
LaSalle Street Capital Management LLC Sells 833 Shares of FedEx Co.
New York State Common Retirement Fund Sells 334,000 Shares of Ford Motor
New York State Common Retirement Fund Sells 334,000 Shares of Ford Motor
61,940 Shares in Triple-S Management Co.  Purchased by Municipal Employees Retirement System of Michigan
61,940 Shares in Triple-S Management Co. Purchased by Municipal Employees Retirement System of Michigan
Bio-Techne  Shares Bought by Municipal Employees Retirement System of Michigan
Bio-Techne Shares Bought by Municipal Employees Retirement System of Michigan
First Solar, Inc.  Position Increased by Municipal Employees Retirement System of Michigan
First Solar, Inc. Position Increased by Municipal Employees Retirement System of Michigan
Micron Technology, Inc.  Position Raised by Municipal Employees Retirement System of Michigan
Micron Technology, Inc. Position Raised by Municipal Employees Retirement System of Michigan


Leave a Reply

 
© 2006-2018 Zolmax.